Duane Mitchell, Photo Credits: Mindy C. Miller


Neuro team mobilizes immune system against tumors
By Michelle Koidin Jaffee

Elias Sayour spent years working toward becoming a pediatric oncologist so he could help kids fight cancer. He always imagined taking care of patients; he didn’t think research was really his thing.

But as a fellow in training, Sayour was struck — overwhelmed, really — by two aspects of his work: One was the toxicity of current treatments and the toll they took, with young children suffering the effects of systemic chemotherapy and radiation on their developing brains and surgeries that invariably removed portions of brain tissue along with tumors.

The other was that the therapy itself would sometimes kill by causing an infection or other medical issue.

Sayour was not sure he could continue on this path.

“Seeing it day-in and day-out, seeing these children go through the after-effects of treatment, was something I had a very hard time with,” says Sayour. “Even when we cured these patients, it came at such a cost.”

When a colleague asked about his focus for the research portion of his fellowship, Sayour said he wished there were something like a cancer vaccine — unaware such a thing was in development right where he was, at Duke University. His colleague told him, “You have to meet this guy, Duane Mitchell.”

“I met Dr. Mitchell,” Sayour says, “and he just spoke a completely different language. He said exactly what I wanted to hear: ‘This is unacceptable, we need to do something about it, we need to attack cancer in a focused, targeted way that spares normal tissue.’”

Sayour went on to do his research under Mitchell, whose focus was on developing techniques to fight brain cancer using immunotherapy, or prompting a patient’s own immune system to target malignant tumor cells.

Elias Sayour is striving to formulate vaccines that can reprogram the immune system to combat cancer. Photo Credits: Mindy C. Miller

Now, Sayour has joined Mitchell in his burgeoning Brain Tumor Immunotherapy Program at the University of Florida. In just three years since Mitchell moved from Duke to UF, he has built a team that is attracting national attention.

This year, Mitchell and his team were recognized nationally for outstanding achievement in clinical research. Glioblastoma is the deadliest brain cancer in adults, with an average survival time of 15 to 18 months. The research conducted at UF and Duke has shown that patients who received an enhanced cancer vaccine had a significant improvement in overall survival length. The resulting paper was named by the Clinical Research Forum as one of the top 10 papers in clinical and translational science in all of U.S. scientific literature in 2015.

That accomplishment was the culmination of years and years of work, Mitchell says — lab work, preclinical work, animal models, a first-in-human clinical trial and follow-up care.

“Thinking about the number of people who worked together and contributed to that achievement, it was so nice to have it recognized,” he says.

His team believes it is only a start.

Their program, which is part of the Preston A. Wells Jr. Center for Brain Tumor Therapy at UF (co-directed by Mitchell and neurosurgery Chair William A. Friedman), is now launching a large, phase 2 first-in-human trial to confirm the benefits of the cancer vaccine. With funding from the National Cancer Institute for a five-year study, they will enroll 120 glioblastoma patients in the randomized trial.

Moreover, Mitchell’s program is known for its focus on pediatric cancer as well as adult cancer. Mitchell is also leading an immunotherapy trial for children with recurrent medulloblastoma, the most common type of pediatric malignant brain tumor.

“When I look at immunotherapy groups across the country, I cannot think of a single one that has as much effort in pediatric brain tumor immunotherapy as this group,” Sayour says.

Catherine Flores’ research is focused on developing immunotherapy regimens for children with treatment-resistant brain cancers. Photo Credits: Mindy C. Miller

The team of five M.D.s and Ph.D.s in addition to Mitchell — Sayour, Maryam Rahman, Catherine Flores, Jianping Huang and Sridharan Gururangan — came together under — and because of — his leadership.

“As clinicians, we need to bridge the gap with scientists, and scientists need to bridge the gap with clinicians,” says Gururangan, director of pediatric neuro-oncology and the newest member of the team. Mitchell “nurtures the protocol right through and is prepared to go back to the lab and use whatever is happening in the lab to fine-tune the protocol. That is very important.”

Each of the six scientists is leading specific projects to advance new treatments, under an integrated, coordinated effort involving more than 30 nurses, postdoctoral fellows, graduate students and administrative staff members.

There are three phases to their work: A preclinical research team evaluates new approaches before they’re ready to be tested; a development team works to move treatments out of the lab and navigates Food and Drug Administration requirements; and a clinical research team carries out the clinical trials. The teams span at least nine different departments or divisions in the UF College of Medicine and include 16 additional faculty members.

“We work together to make sure that the things we’re advancing within the laboratory setting ultimately have a focus on how we are going to make a difference for patients,” Mitchell says. “One of the distinguishing characteristics of the program here — and a testament to the University of Florida’s capacity and support for the work — is that we are able to take treatments that are literally discovered in the laboratory setting and then bring them to clinical application and make them available for clinical trial evaluation in patients.

“That translational capacity means that patients seek out the University of Florida because the trials are unique in being offered for the first time to patients,” he says. “A center that supports that type of work takes a huge amount of intellectual resources, physical resources, infrastructural resources and financial resources to have an environment where you conduct those trials and do it safely.”

Doing this work has been a long-held dream for Mitchell, whose interest in cancer immunotherapy dates back to when he was an undergrad at Rutgers University. That’s when he first came to understand the concept of a physician-scientist, one who treats as well as develops new treatments, and he was enthralled by the book “The Transformed Cell: Unlocking the Mysteries of Cancer,” by immunotherapy pioneer Steven A. Rosenberg.

Immunotherapy “made a lot of sense to me,” Mitchell says. “The lesson I remember from it is, the immune system should recognize tumors as foreign, and if it did that appropriately, it would reject those cancers and have the ability to remember what it’s rejected, so if it ever comes back, attack it again. That was so different than any other modality for treating a disease I had heard about.”

From then on, Mitchell strove to assemble a personal roadmap toward what he now calls “translational neuro-oncology” or “translational immunotherapy.”

“I had a picture of what an institution needs to have in place as a vision to really make a significant impact in this field,” Mitchell says. “There has to be an institutional vision and a commitment not just from the scientists, not just the physicians, but the medical school, the hospital and the cancer center. The institution needs to be committed to being a leader and making a difference in this area to be successful.

“When I came to visit UF, I saw that those elements were here — all the requisite infrastructure was here to do that, and the commitment and institutional vision to make UF a leader was also here,” he says.

Among those he’s recruited in this effort is Huang, who worked under Rosenberg at the National Cancer Institute for seven years and got to witness complete remissions in patients with metastatic melanoma. “That really inspired me to work hard on the project,” says Huang, now director of clinical laboratory operations for the UF Brain Tumor Immunotherapy Program, also known as BTIP.

Elias Sayour, Catherine Flores, Postdoctoral Associate Kate Candelario and Duane Mitchell in their lab at the McKnight Brain Institute. Photo Credits: Mindy C. Miller

Huang felt drawn to working on brain tumors because survival is so short, she says. With brain tumor, compared with melanoma, immunotherapy is in the early stages. “It’s really a new field, and we can do a lot of things,” she says. “In my heart I think we will do something. I have that hope and confidence that someday we will make a huge difference.”

It can’t come too soon.

Flores, principal investigator of BTIP’s hematopoietic stem cell engineering laboratory, says far too often she has written the following words on a grant application: “Median survival is about a year.”

“It’s very dim,” Flores says. “The standard of care for brain tumors for pediatrics and adults does very little.”

Nonetheless, she feels a great sense of hope for the future.

“I feel like at the rate Dr. Mitchell puts things in clinic, I think we’re definitely getting there,” she says. “Hopefully, with the years to come and with funding and donors and more support, we will be able to overcome the dire need.”


  • Duane Mitchell, Professor of Neurosurgery, co-director of UF’s Preston A. Wells Jr. Center for Brain Tumor Therapy, and head of the Cancer Therapeutics & Immuno-Oncology program at the UF Health Cancer Center

Related Website:

Related Video:

Dr. Duane Mitchell discusses the e use of immunotherapy to treat brain cancers and the importance of philanthropy to innovations in treatment options.

This article was originally featured in the Fall 2016 issue of Explore Magazine.

左手视频下载app视频免费最新 iAVBOBO下载app视频免费最新 富二代f2抖音app 月夜直播app 快播破解app 花秀神器 猫咪软件 大西瓜视频app 泡泡直播app 含羞草视频 九尾狐直播app 小天仙直播app ML聚合直播下载app视频免费最新 茄子视频 MM直播下载app视频免费最新 泡泡直播app 成人快手app 么么直播app 7秒鱼下载app视频免费最新 最污直播app 菠萝菠萝蜜视频 享受直播app 享爱直播 快猫app 西瓜直播app 茄子直播下载app视频免费最新 和欢视频 花心社区 九尾狐直播 后宫 小v视频app 豆奶 骚虎直播app bobo直播app 尤蜜视频app 咪咪直播 向日葵 花姬直播app 月亮视频app 富二代f2app 遇见直播 豆奶 奶茶视频 大秀直播 黄鱼视频 七秒鱼 BB直播app 久草app 粉色app 探花直播 f2富二代 探探直播 iAVBOBO 性福宝 红颜app 月亮视频app 泡芙 牛牛视频app 蜜柚 东京视频 木瓜视频app 可乐视频 91香蕉视频 逗趣直播 笔芯直播app 黄色直播软件 年轻人片app 卡哇伊app 樱桃 比心直播app 一对一直播 盘她直播app 美岁直播 内裤直播 小狐仙视频app 小喵直播app 蜜柚直播 花仙子直播 芭乐app 月亮视频 可乐视频app 花秀神器 向日葵视频 享爱 蓝精灵直播app 芭乐app avgoapp 成人直播 草莓直播 灭火卫视app 9uuapp 向日葵视频app 小草莓 四虎 好嗨哟直播app 葫芦娃app 香蜜直播 bobo直播 迷雾直播 含羞草实验研究所 幸福宝下载app视频免费最新 蜜橙视频app 月光直播app s8视频app BB直播 夜巴黎直播app 抖阴 小酒窝直播 妖妖直播app JOJO直播 和欢视频app 小蝌蚪视频 麻豆传媒映画app 酷咪直播 小蝌蚪视频 青草视频 和欢视频下载app视频免费最新 富二代短视频 午夜直播间app 荔枝app 7秒鱼下载app视频免费最新 烟花巷 免费黃色直播app 粉色app 猛虎直播app 夏娃直播app 蜜桃直播 富二代f2抖音app 小狐仙视频 小宝贝直播 香蜜直播 夜夜直播app 红玫瑰直播下载app视频免费最新 老王视频 富二代f2短视频 花姬app 么么直播app 幸福宝下载app视频免费最新 小酒窝直播app 91香蕉视频app 樱花app 91香蕉视频app 金鱼直播 后宫app 夜魅直播 bobo直播app 红娘直播app 考拉直播 豆奶短视频 尤蜜app 依恋直播 月亮直播app 小宝贝直播app 遇见直播app 好嗨哟直播app 蜜柚直播app 成版人抖音富二代 A头条 蝶恋花 探探直播app 蜜桃 望月下载app视频免费最新 樱桃视频app 月光直播 香草成视频人app 夜狼直播 猛虎直播app 直播盒子app 享爱 花姿 秀儿直播下载app视频免费最新 好嗨哟直播 avgo下载app视频免费最新 盘她直播 JOJO直播下载app视频免费最新 芭乐 享爱直播app 微啪app 月色直播app 泡芙视频app 桃花直播app 小蝌蚪视频app 久草app 成版人短视频 七秒鱼直播app 富二代 小优 health2 好嗨哟直播下载app视频免费最新 柠檬直播 猛虎视频app 美梦视频app 成版人抖音富二代 成版人抖音富二代 千层浪 小宝贝直播app 丝瓜 红楼直播app 茶馆视频 月色直播 雨燕直播 7秒鱼直播 杏吧直播 swag台湾 冈本视频app 小蝌蚪 久草app 7秒鱼直播 快狐短视频 黄瓜app 91香蕉app 红楼直播app 可乐视频app 秀色小抖音app 咪哒直播 大小姐直播 比心直播app 宅男之家 享受直播app 7秒鱼app 小仙女app 色秀直播 米老鼠直播 JAV名优馆下载app视频免费最新 午夜神器app 盘他 麻豆传媒直播 葫芦娃视频 彩云直播app 咪哒直播app 成版人抖音富二代 小怪兽直播app 小天仙直播app 灭火卫视 木瓜 享爱app 月色直播 91香蕉 月色直播 盘她 芭乐视频app 青草视频 红楼直播app 硬汉视频下载app视频免费最新 千层浪视频app 泡芙短视频app 享受直播 小怪兽app 逗趣直播 左手视频app 啪嗒视频 玉米视频app 久草视频app 豌豆直播app health2下载app视频免费最新 夜魅直播 草莓视频app 91直播 盘他直播app 性福宝app 小奶狗app 米老鼠直播 水仙直播app 卡哇伊直播app 咪哒直播app 番茄社区 番茄社区 蚪音 主播福利app 小猪视频app 橙子直播app 葡萄视频 快猫视频app 西瓜直播 斗艳直播app 粉色app 么么直播app 蜜柚 花心社区app 遇见直播app 草榴直播 蝶恋花app 91视频 橘子视频 花心视频app 小怪兽 可乐视频app f2富二代app 彩云直播app 秋葵视频 久草视频 黄瓜 豌豆直播app 初见直播app 蜜桃直播 春水堂 盘他直播 秀儿直播 年华直播 樱桃视频 美梦视频 f2富二代 夜狼直播app 秀色直播app 97豆奶视频下载app视频免费最新 樱桃app 花友直播 ML聚合直播 茶馆视频下载app视频免费最新 卡哇伊直播 成版人抖音富二代app 尤蜜视频 花姬 黄瓜直播 花姬直播app 丝瓜 木瓜 梦露直播app s8视频app 香草视频app 食色短视频 樱花雨直播下载app视频免费最新 尤蜜视频app 光棍影院app 丝瓜草莓视频app 左手视频 IAVBOBOapp 69视频下载app视频免费最新 陌秀直播 本色视频 小天仙直播app 九尾狐直播 雨云直播app 69视频 秀儿直播下载app视频免费最新 夜魅直播 酷咪直播app 暗夜直播 JAV名优馆 后宫视频 享爱app 秀儿直播下载app视频免费最新 媚妹秀 梦鹿直播app 茄子直播app d2天堂app 一对一直播app 香蕉app ML聚合app 小公主直播 比心直播 繁花直播 BB直播 IAVBOBO 好嗨哟直播下载app视频免费最新 向日葵 香蜜直播 91直播下载app视频免费最新 秀儿直播下载app视频免费最新 9uuapp 四虎 九尾狐视频 西瓜直播app 大小姐直播 彩色直播 圣女直播app 草莓 含羞草app 青草视频 小公主直播app 千层浪直播app 遇见直播 富二代短视频 9uuapp 夜魅直播 番茄直播app 茄子app iavbobo下载app视频免费最新 香蕉视频app 梦幻直播app 男人本色西瓜视频app 咪哒 七秒鱼直播 午夜直播间 小酒窝直播 粉色 ML聚合 成版人短视频app 富二代短视频 MM直播app 黄瓜app 花仙子直播下载app视频免费最新 好嗨哟直播下载app视频免费最新 光棍影院 69视频 梦幻直播 小狐仙 泡芙app 灭火卫视 红玫瑰直播app JOJO直播下载app视频免费最新 杏花直播 粉色视频app 色秀直播app MM直播 红颜 丝瓜视频污 秋葵视频 蓝颜 快播破解app 火爆社区app 番茄视频app iavbobo 野花视频 樱桃app 快播破解app 月亮直播app 9uu MM直播下载app视频免费最新 黄页荔枝 灭火卫视 花姬直播app 金鱼直播app 麻豆视频 fi11含羞草 暗夜直播app 69视频 污直播app 夜巴黎直播 烟花巷直播 bobo直播app 夜魅直播 彩云直播 小米粒直播下载app视频免费最新 红高粱直播app 香蕉直播 小狐仙 花心视频app 可乐视频app 浪浪视频app 逗趣直播 好嗨哟直播 榴莲视频app 富二代f2抖音app 夜巴黎直播 东京视频app AVBOBO下载app视频免费最新 蜜橙视频app 美岁直播app 九尾狐直播 性直播 小奶猫app 快狐短视频 木瓜app 快喵 酷咪直播 内裤直播 合欢视频 初恋视频 小草莓app iAVBOBOapp 浪浪视频 7秒鱼 丝瓜草莓视频app 铁牛 暖暖直播app 水蜜桃 桃花直播app 含羞草app 云上花直播下载app视频免费最新 水果视频app 红楼直播 粉色视频 花仙子直播 富二代短视频 草榴直播 葫芦娃 泡芙 樱花直播app 棉花糖直播 茄子app ML聚合 乐购直播 爱爱视频app 梦露直播 暗夜直播 七秒鱼app 红杏视频 榴莲视频app iAVBOBO 嘿嘿连载 七仙女直播app 草榴直播app 荔枝视频 花友直播 蜜桃 心上人直播 小姐姐直播app 蜜橙视频app 食色短视频 可乐视频app 富二代app 迷雾直播 奶茶视频 柠檬视频app 秀儿直播app 直播盒子app 黄瓜 东京视频app 斗艳直播app iavbobo下载app视频免费最新 可乐视频 望月直播 大小姐直播 抖阴 心上人直播 梦幻直播app 夜魅直播 黄鱼视频 猫咪软件app 豆奶短视频 性直播 后宫 仙人掌app 芭乐app 享爱 西瓜直播 荔枝视频 金鱼直播app 佳丽直播视频 小花螺直播 荔枝app 香草成视频人app 盘他app 春水堂视频 葡萄视频app 橘子直播 菠萝蜜 老王视频app 媚妹秀app 直播盒子 番茄直播 BB直播 恋夜秀场 梦幻直播 彩色直播app 音色短视频app 草莓app 繁花直播app 红楼直播 最污直播app 草榴视频 菠萝蜜app 和欢视频 小姐姐直播app 菠萝蜜视频 91香蕉 蝶恋花app 大秀直播 蓝颜app 食色app 直播盒子app 草榴短视频 年华直播 葫芦娃 望月直播 彩云直播app 快喵app 幸福宝app 樱花直播 水晶直播 小姐姐直播 小米粒直播下载app视频免费最新 快猫短视频下载app视频免费最新 快猫视频 水果视频app 富二代f2抖音app 猫咪视频app 7秒鱼 硬汉视频 四虎 蜜桃直播app 泡泡直播app 小狐仙app 香蜜直播app 微杏 木瓜下载app视频免费最新 月光直播app 望月下载app视频免费最新 小奶狗 Huluwaapp 鲍鱼视频app 冈本app 大菠萝app 丝瓜 f2富二代app 食色app 小奶狗视频 快播破解app